Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06839898

A Prospective, Randomized Clinical Study of Two Phakic Toric Implantable Lenses

A Prospective, Randomized Clinical Study of Two Phakic Toric Implantable Lenses to Compare Outcomes in Patients With Moderate to High Myopia and Astigmatism

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
172 (estimated)
Sponsor
Biotech Healthcare Holding Gmbh · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

Primary Objective: To compare the efficacy and the residual refractive error of EYECRYLTM Phakic toric versus Visian® Toric ICL in moderate to high myopic patient with co-existing astigmatism. Secondary Objectives: To evaluate and compare the safety of EYECRYLTM Phakic toric versus Visian® Toric ICL in moderate to high myopic patients with co-existing astigmatism.

Detailed description

Phakic intraocular lenses are clear implantable lenses that are surgically placed either in anterior chamber (AC) or posterior chamber (PC) without removing the natural lens, enabling light to focus on the retina for improved uncorrected visual acuity. Phakic intraocular lenses demonstrate high optical quality and potential gain in visual acuity in myopic patients due to retinal magnification. Toric version of phakic intraocular lens is intended to correct both myopia and astigmatism.1

Conditions

Interventions

TypeNameDescription
DEVICEEYECRYLTM Phakic Toric Intraocular Lens Treatment ArmThe patients will be implanted with Eyecryl Phakic IOL at this arm based on randomization.Phakic intraocular lenses are clear implantable lenses that are surgically placed either in anterior chamber (AC) or posterior chamber (PC) without removing the natural lens, enabling light to focus on the retina for improved uncorrected visual acuity. Phakic intraocular lenses demonstrate high optical quality and potential gain in visual acuity in myopic patients due to retinal magnification. Toric version of phakic intraocular lens is intended to correct both myopia and astigmatism.
DEVICEVisian® Toric ICL Treatment ArmThe patients will be implanted with Visian® Toric Implantable Contact Lens at this arm based on randomization. Phakic intraocular lenses are clear implantable lenses that are surgically placed either in anterior chamber (AC) or posterior chamber (PC) without removing the natural lens, enabling light to focus on the retina for improved uncorrected visual acuity. Phakic intraocular lenses demonstrate high optical quality and potential gain in visual acuity in myopic patients due to retinal magnification. Toric version of phakic intraocular lens is intended to correct both myopia and astigmatism.

Timeline

Start date
2021-10-10
Primary completion
2025-08-01
Completion
2027-02-01
First posted
2025-02-21
Last updated
2025-02-21

Locations

4 sites across 2 countries: Germany, India

Source: ClinicalTrials.gov record NCT06839898. Inclusion in this directory is not an endorsement.